TuisCONCORDBIO • NSE
add
Concord Biotech Ltd
Vorige sluiting
₹1 557,80
Dagwisseling
₹1 510,10 - ₹1 583,00
Jaarwisseling
₹1 327,05 - ₹2 664,00
Markkapitalisasie
158,61 mjd INR
Gemiddelde volume
77,60 k
P/V-verhouding
41,12
Dividend-opbrengs
0,58%
Primêre beurs
NSE
Marknuus
Investor's Business Daily
3 uur gelede
Investors Score On These 10 Popular ETFs — None Own The S&P 500
1,16%
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (INR) | Des. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 2,44 mjd | 1,42% |
Bedryfskoste | 806,93 m | -20,36% |
Netto inkomste | 759,21 m | -2,13% |
Netto winsgrens | 31,09 | -3,51% |
Wins per aandeel | 7,26 | -2,02% |
EBITDA | 976,51 m | -7,52% |
Effektiewe belastingkoers | 24,94% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (INR) | Des. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 2,84 mjd | 26,07% |
Totale bates | — | — |
Totale aanspreeklikheid | — | — |
Totale ekwiteit | 15,90 mjd | — |
Uitstaande aandele | 104,57 m | — |
Prys om te bespreek | 10,25 | — |
Opbrengs op bates | — | — |
Opbrengs op kapitaal | 13,28% | — |
Kontantvloei
Netto kontantverandering
| (INR) | Des. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 759,21 m | -2,13% |
Kontant van bedrywe | — | — |
Kontant van beleggings | — | — |
Kontant van finansiering | — | — |
Netto kontantverandering | — | — |
Beskikbare kontantvloei | — | — |
Meer oor
Concord Biotech Limited is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation-based biopharmaceutical active pharmaceutical ingredients sold worldwide.
It manufactures biopharmaceutical products across therapy segments such as immunosuppressant, oncology, antifungal, antibacterial and anthelmintic. It has two manufacturing facilities–at Dholka near Ahmedabad, which is approved by USFDA, and at Limbasi in Kheda district. Wikipedia
Gestig
2000
Webwerf
Werknemers
1 377
